NDRA vs. JAGX

In the year-to-date period, NDRA achieves a -46.49% return, which is significantly higher than JAGX's -82.57% return.

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

This table presents a comparison of risk-adjusted performance metrics for ENDRA Life Sciences Inc. (NDRA) and Jaguar Health, Inc. (JAGX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

The current NDRA Sharpe Ratio is -0.47, which is higher than the JAGX Sharpe Ratio of -0.73. The chart below compares the historical Sharpe Ratios of NDRA and JAGX, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Neither NDRA nor JAGX has paid dividends to shareholders.

The maximum NDRA drawdown since its inception was -99.97%, roughly equal to the maximum JAGX drawdown of -100.00%. Use the drawdown chart below to compare losses from any high point for NDRA and JAGX.

ENDRA Life Sciences Inc. (NDRA) has a higher volatility of 69.88% compared to Jaguar Health, Inc. (JAGX) at 45.28%. This indicates that NDRA's price experiences larger fluctuations and is considered to be riskier than JAGX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

This section allows you to compare key financial metrics between ENDRA Life Sciences Inc. and Jaguar Health, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.